CRISPLD2 Is Expressed at Low Levels during Septic Shock and Is Associated with Procalcitonin

Abstract

The present study is the first to demonstrate the decreased expression of CRISPLD2 in septic shock and its association with PCT in sepsis. Further studies are needed to clarify the potential association between CRISPLD2 expression and clinical outcomes to determine if it could be used as a novel sepsis biomarker.